Ampliphi Biosciences Corp (NYSEAMERICAN:APHB - Get Free Report) shares rose 1% on Monday . The company traded as high as $1.95 and last traded at $1.93. Approximately 23,983 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 842,200 shares. The stock had previously closed at $1.91.
Ampliphi Biosciences Stock Performance
The company's 50-day moving average price is $1.61 and its two-hundred day moving average price is $1.89.
Ampliphi Biosciences Company Profile
(
Get Free Report)
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Recommended Stories
Before you consider Ampliphi Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ampliphi Biosciences wasn't on the list.
While Ampliphi Biosciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
